Scientific article
OA Policy
English

The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy

Published inActa Oncologica, vol. 56, no. 4, p. 569-574
Publication date2017
Abstract

Androgen deprivation (AD) therapy combined to radiotherapy (RT) is a curative therapeutic option for patients with non-metastatic locally advanced or aggressive intermediate prostate cancer (PC), though with a range of nutritional, physical, and psychological side effects. A multidisciplinary care program was created to help frail patients to prevent and manage those side effects.

Keywords
  • Aged
  • Androgen Antagonists/administration & dosage/adverse effects
  • Chemoradiotherapy/adverse effects
  • Counseling
  • Frail Elderly
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Physical Therapy Modalities
  • Prostatic Neoplasms/psychology/rehabilitation/therapy
  • Psychotherapy
  • Quality of Life
Citation (ISO format)
MARESCHAL, Julie et al. The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy. In: Acta Oncologica, 2017, vol. 56, n° 4, p. 569–574. doi: 10.1080/0284186X.2016.1273545
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN0284-186X
614views
371downloads

Technical informations

Creation13/11/2017 14:32:00
First validation13/11/2017 14:32:00
Update15/03/2023 02:20:01
Status update15/03/2023 02:20:00
Last indexation31/10/2024 08:32:23
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack